Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Colonic Diseases D003108 5 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Strongylida Infections D017206 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Sneezing D012912 6 associated lipids
Thrombophilia D019851 6 associated lipids
Gliosis D005911 6 associated lipids
Heart Injuries D006335 6 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Klebsiella Infections D007710 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Conjunctivitis D003231 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Wolf P et al. Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. 2006 Am. J. Pathol. pmid:16936256
Pirbhai M et al. The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. 2006 J. Biol. Chem. pmid:16940052
Harputluoglu MM et al. The effects of Gingko biloba extract on acetic acid-induced colitis in rats. 2006 Turk J Gastroenterol pmid:16941250
Han JI et al. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. 2006 J. Leukoc. Biol. pmid:16565322
Servillo L et al. Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages. 2006 FASEB J. pmid:16571775
Flamand N et al. Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF. 2006 J. Leukoc. Biol. pmid:16501051
He J and Bazan HE Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. 2006 Invest. Ophthalmol. Vis. Sci. pmid:16505020
Barthomeuf C et al. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. 2006 Free Radic. Biol. Med. pmid:16458188
Marchand C et al. Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cells. 2006 J. Cell. Biochem. pmid:16479592
Buchanan MR Biological basis and clinical implications of acetylsalicylic acid resistance. 2006 Can J Cardiol pmid:16485051
Heinrich S et al. Evidence-based treatment of acute pancreatitis: a look at established paradigms. 2006 Ann. Surg. pmid:16432347
Chiang KP et al. An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. 2006 Chem. Biol. pmid:17052608
Brown SL et al. Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. 2006 J. Immunol. pmid:16920964
Baker KE et al. Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation? 2006 Br. J. Pharmacol. pmid:16921398
Kim DH et al. Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. 2006 Ann. Otol. Rhinol. Laryngol. pmid:16944661
Vahidy WH et al. Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. 2006 Exp Brain Res pmid:16947060
Matsumura Y et al. A role for inflammatory mediators in the induction of immunoregulatory B cells. 2006 J. Immunol. pmid:16982922
Slomiany BL and Slomiany A Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation interferes with salivary mucin synthesis via platelet activating factor generation. 2006 Inflammopharmacology pmid:16983494
Zhang Q et al. Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. 2006 Exp. Dermatol. pmid:16984258
Hartvigsen K et al. 1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB. 2006 Lipids pmid:17069352
Sugimoto S et al. Purification and characterization of lysophospholipase D from rat brain. 2006 Biochim. Biophys. Acta pmid:17071136
Fallani A et al. Platelet-activating factor (PAF) is the effector of IFN gamma-stimulated invasiveness and motility in a B16 melanoma line. 2006 Prostaglandins Other Lipid Mediat. pmid:17085325
Slomiany BL and Slomiany A Leptin modulates the detrimental effect of Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation on salivary mucin synthesis via ERK-signal transduction. 2006 Inflammopharmacology pmid:17093905
Fernandes CJ and O'Donovan DJ Platelet transfusions in infants with necrotizing enterocolitis. 2006 Curr. Hematol. Rep. pmid:16537050
Maliba R et al. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. 2006 Cell. Signal. pmid:16617006
Jauchem JR The role of autacoids and the autonomic nervous system in cardiovascular responses to radio-frequency energy heating. 2006 Auton Autacoid Pharmacol pmid:16553641
Bi W et al. Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates. 2006 Bioorg. Med. Chem. Lett. pmid:16797986
Purnell ET et al. Influence of the preimplantation embryo development (Ped) gene on embryonic platelet-activating factor (PAF) levels. 2006 J. Assist. Reprod. Genet. pmid:16799834
Slomiany BL and Slomiany A Cytosolic phospholipase A2 activation in Helicobacter pylori lipopolysaccharide-induced interference with gastric mucin synthesis. 2006 IUBMB Life pmid:16754300
Moreno SE et al. Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. 2006 J. Immunol. pmid:16818786
Machado EM et al. WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph. 2006 J. Insect Physiol. pmid:16777137
Blanchet MR et al. Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. 2006 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:16782754
Gomes RN et al. Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. 2006 Shock pmid:16783197
Chen LW et al. Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent. 2006 Shock pmid:16783201
Sneddon AA et al. Cytokine-induced monocyte adhesion to endothelial cells involves platelet-activating factor: suppression by conjugated linoleic acid. 2006 Biochim. Biophys. Acta pmid:16829183
Holder E et al. Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation. 2006 Gene Ther. pmid:16791284
Kaneko MK et al. Conservation of a platelet activating domain of Aggrus/podoplanin as a platelet aggregation-inducing factor. 2006 Gene pmid:16766141
Wang C et al. Total synthesis of (+/-)-paeonilide. 2006 Org. Lett. pmid:16737293
Kaul DK et al. Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation. 2006 Am. J. Physiol., Cell Physiol. pmid:16738001
Thaete LG and Neerhof MG Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. 2006 Am. J. Obstet. Gynecol. pmid:16579936
Karantonis HC et al. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. 2006 Nutr Metab Cardiovasc Dis pmid:16580585
Balestrieri C et al. Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis. 2006 Biochem. Pharmacol. pmid:16580641
Poeckel D et al. 3-O-acetyl-11-keto-boswellic acid decreases basal intracellular Ca2+ levels and inhibits agonist-induced Ca2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells. 2006 J. Pharmacol. Exp. Ther. pmid:16174802
Fang H et al. Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70. 2006 Int. Immunol. pmid:16943259
Antonopoulou S et al. Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. 2006 J Med Food pmid:17004898
Gomes MT et al. Platelet-activating factor-like activity isolated from Trypanosoma cruzi. 2006 Int. J. Parasitol. pmid:16337632
Dohi T et al. [Role of platelet-activating factor on spinal pain transduction]. 2006 Nippon Yakurigaku Zasshi pmid:16508219
Karidis NP et al. Platelet-activating factor in liver injury: a relational scope. 2006 World J. Gastroenterol. pmid:16773686
Chu WF et al. Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway. 2006 Basic Clin. Pharmacol. Toxicol. pmid:16433899
Ozturk H et al. PAF antagonist BN-52021 reduces intercellular adhesion molecule-1 expression and oxidative stress in rats with reperfusion damage due to unilateral testicular torsion. 2006 Pediatr. Surg. Int. pmid:16369775